Catherine M. Avitabile, MD

faculty photo
Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
Children's Hospital of Philadelphia
34th Street and Civic Center Boulevard
Philadelphia, PA 19104
Education:
BA (Economics)
Univesity of Notre Dame, 2003.
MD (Medicine)
Columbia University College of Physicians and Surgeons, 2007.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Pulmonary hypertension
Echocardiography
Pulmonary vein stenosis
Bronchopulmonary dysplasia
Congenital diaphragmatic hernia

Description of Research Expertise

Pulmonary hypertension
Fontan physiology
Peripheral determinants of exercise capacity
Exercise training
Right ventricular function
Congenital diaphragmatic hernia

Selected Publications

Avitabile CM, Saavedra S, Sivakumar N, Goldmuntz E, Paridon SM, Zemel BS: Marked skeletal muscle deficits are associated with 6-minute walk distance in paediatric pulmonary hypertension. Cardiol Young February 2021 Notes: Epub ahead of print. doi: 10.1017/S1047951121000342.

Avitabile CM, Wang Y, Zhang X, Griffis H, Saavedra S, Adams S, Herkert L, Frank DB, Quartermain MD, Rintoul NE, Hedrick HL, Mercer-Rosa L. : Right ventricular strain, brain natriuretic peptide, and mortality in congenital diaphragmatic hernia Ann Am Thorac Soc 17(11): 1431-1439, November 2020.

O'Byrne ML, Faerber J, Katcoff H, Frank D, Davidson A, Giglia T, Avitabile CM: Variation in the use of pulmonary vasodilators in children and adolescents with pulmonary hypertension: A study using data from the Marketscan Insurance Claims Database. Pulmonary Circulation May 2020.

Lawrence KM, Monosa S, Adams S, Herkert L, Peranteau WH, Munson DA, Hopper RK, Avitabile CM, Rintoul NE, Hedrick HL: Inhaled nitric oxide is associated with improved oxygenation in a sub-population of infants with congenital diaphragmatic hernia and pulmonary hypertension. J Pediatr 219: 167-172, April 2020.

Avitabile CM, Vorhies EE, Ivy DD: Drug treatment of pulmonary hypertension in children. Pediatric Drugs 22(2): 123-147, April 2020.

Sun H, Ivy DD, Stockbridge N, Handler SS, Bates A, Krishnan U, Yung D, Hopper RK, Fineman J,. Varghese NP, Austin ED, Avitabile CM, Freire G, Mullen MP: Utilizing actigraphy to measure impact of genetic mutations on heart rate variability in pediatric pulmonary arterial hypertension. Virtual poster presentation due to COVID19, American Thoracic Society, November 2020. 2020.

Gardner MM, Faerber J, Preminger T, Avitabile CM, Shankar S, Glatz AC, Ravishankar C, Goldberg DJ: Relationship between brain-type natriuretic peptide and serum growth factors in infants with single ventricle heart disease and shunt- or ductal-dependent pulmonary blood flow. Virtual presentation due to COVID19, American Heart Association Scientific Sessions, November 2020 2020.

Tong Y, Udupa JK, McDonough JM, Wu C, Qiu C, Lott C, Galagedera N, Avitabile CM, Anari JB, Torigian DA, Cahill PJ: Pulmonary hypertension (PH) and thoracic cage function in patients with early onset scoliosis: assessment with quantitative dynamic magnetic resonance imaging (QdMRI). Virtual presentation due to COVID 19. Scoliosis Research Society 55th Annual Meeting, September 2020. 2020.

Austin E and the Pediatric Pulmonary Hypertension Bronchopulmonary Dysplasia Working Group (including Avitabile CM) : Pulmonary hypertension in bronchopulmonary dysplasia - The need for continued outpatient surveillance beyond infancy. Virtual poster discussion session due to COVID19, American Thoracic Society, November 2020 2020.

O’Byrne ML, Faerber J, Katcoff H, Huang J, Edelson J, Finkelstein D, Avitabile CM, Glatz AC, Goldberg DJ: Prevalent pharmacotherapy in United States children and adolescents after Fontan completion: An analysis of data from the Marketscan® Commercial and Medicaid databases Virtual presentation due to COVID19, American Heart Associations Scientific Sessions, November 2020. 2020.

back to top
Last updated: 04/16/2021
The Trustees of the University of Pennsylvania